ArticleInternational journal of chronic obstructive pulmonary disease2021

Economic Evaluation of Umeclidinium/Vilanterol versus Umeclidinium or Salmeterol in Symptomatic Non-Exacerbating Patients with COPD from a UK Perspective Using the GALAXY Model.

Soham Shukla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.